Cardiogenic Shock
Cardiogenic shock is a critical condition where the heart suddenly can't pump enough blood to meet the body's needs, often resulting from severe heart problems like a heart attack or sepsis.
Procizumab for Critical Cardiovascular Care
We are evaluating a new treatment for patients receiving critical care for cardiovascular issues. This study aims to understand its safety and potential benefits in this high-risk group.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
CHU Saint-Pierre
intensive care unit
Saint-Gilles, Belgium
Institute For Clinical And Experimental Medicine
cardiology department
Prague, Czechia
Vseobecna Fakultni Nemocnice V Praze
cardiology department
Prague, Czechia
Sponsor: 4TEEN4 Pharmaceuticals GmbH
Last updated: Nov 27, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.